Advancing women's & reproductive health through research and education
Welcome to the Nuffield Department of Women's and Reproductive Health, a pioneering institution with a rich legacy dating back to 1937.
Our vision is clear: a world where everyone enjoys high-quality, evidence-based women's and reproductive healthcare. Through cutting-edge research and transformative teaching, we're committed to elevating the standard and accessibility of women's healthcare worldwide.
Explore our site to delve into impactful research, academic programs, and our global mission. Join us as we propel the future of women's health—one breakthrough at a time.
Our worldwide acclaimed research covers four main themes; Reproductive Medicine & Genetics, Maternal & Fetal Health, Cancer and Global Health. We also run a range of clinical trials from women who are not currently pregnant, to those in the first trimester of pregnancy and onward, as well as general women's health studies.
Applications are now open for entry in 2024-25! We offer two postgraduate research programmes: a two year MSc by Research and a three year DPhil. These involve students undertaking independent research in their chosen area under the supervision of two or more experts in the field. In addition we offer a one year taught MSc in Clinical Embryology.
We have over 160 members in our department spread across eight sites in Oxford, consisting of post-graduate students, academic and research staff and professional staff. Our people are our life-blood and we are committed to ensuring they feel valued and nurtured as part of the Women's & Reproductive Health community.
Promising advances in Rhino fertility preservation
In a significant stride towards the preservation of rhinoceros fertility, the Rhino Fertility Project, founded by Professor Suzannah Williams, unveils groundbreaking insights into the structure and molecular characteristics of Southern White Rhinoceros ovaries.
Pereira CS. et al, (2023), Scientific Reports, 13
Antihypertensive Treatment Evaluation in Multimorbidity and Polypharmacy Trial (ATEMPT): A decentralised open-label pilot trial
Majert J. et al, (2023), The Lancet. Healthy Longevity
NAGRAJ S. et al, (2023), PLOS Global Public Health